Drug Pipeline & Clinical Trials at Psych Congress 2026

7 sessions on drug pipeline & clinical trials · September 15–19, 2026, New Orleans, LA. Compare drug pipeline & clinical trials at other meetings →

Tuesday, September 15

Course
Advanced Psychopharmacology Intensive: Emerging Neurobiologic Targets and Metabolic Pathways Reshaping Psychiatric Treatment
Brittany Albright · Rakesh Jain · Gregory Mattingly · David Plante
Half-day ticketed intensive built around four expert-led modules on treatment mechanisms moving beyond monoamines: orexin-based agents, glutamate/dopamine circuit approaches, muscarinic receptor modulation, and GLP-1/bioenergetic pathways.
GLP-1 & Metabolic Psychiatry · Muscarinic & Novel Antipsychotics · Neuroscience & Mechanisms
Symposium · MasterClass
MasterClass: Seeing the Bigger Picture: How to Evaluate Real-World Evidence Along with RCTs in Psychiatric Treatment Decisions
Craig Chepke
Teaches clinicians to weigh real-world study designs against randomized trials, including examples where RWE informed FDA-approved psychiatric therapies.
Education & Training

Symposium · Latest Discoveries & Emerging Trends
Latest Discoveries & Emerging Trends in Psychotic Disorders
Christoph U. Correll · Ilan Melnick
Fast-paced review of the year's most significant schizophrenia and psychosis research, with expert commentary and selected poster presenters sharing emerging data.
Schizophrenia & Psychosis

Symposium · Latest Discoveries & Emerging Trends
Latest Discoveries & Emerging Trends in MDD
Rakesh Jain · Michael Thase
Year-in-review of depression research spanning neurobiology, trial results, and pharmacologic and non-pharmacologic innovation, with selected poster presenters showcasing new data.
Depression · Neuroscience & Mechanisms
Symposium · MasterClass
MasterClass: Translating Orexin Science Into Practice: Psychiatry's Role in Narcolepsy Care
Craig Chepke · Logan Schneider · Jessica Wright
Covers orexin-deficiency neurobiology, how to distinguish narcolepsy from psychiatric mimics, and the clinical implications of emerging orexin receptor agonists.
Neuroscience & Mechanisms · Sleep & Insomnia
Symposium · Anxiety Disorders
When Anxiety Persists: Evidence-Based Strategies and Novel Pharmacologic Options Beyond First-Line Treatment
Rakesh Jain · Manish Jha
Step-by-step framework for treatment-resistant anxiety after SSRI/SNRI failure, covering sequencing, psychotherapy integration, and off-label and emerging agents from gabapentinoids to glutamatergic and GABAergic options.
Anxiety Disorders · Psychotherapy

Symposium · Psychedelics
Psychedelics in Psychiatry: Where the Evidence Stands Today and What Comes Next
Charles Raison · Andrew Penn
Evidence-focused update on psychedelic-assisted therapy trials, regulatory developments, and safety considerations, emphasizing separation of validated data from public enthusiasm.
Psychedelics